BiotechTube
Home/C4 Therapeutics/John D. Chodera, Ph.D.
JD

John D. Chodera, Ph.D.

Chief Scientific Officer

C4 Therapeutics

Therapeutic Areas

Oncology

C4 Therapeutics Pipeline

DrugIndicationPhase
Cemsidomide (CFT7455)Relapsed/Refractory Multiple MyelomaPhase 1/2
CFT8919EGFR L858R-mutated Non-Small Cell Lung Cancer (NSCLC)Phase 1

Leadership Team at C4 Therapeutics

AJ
Andrew J. Hirsch
Chief Executive Officer, President & Director
SO
Stephanie Oestreich, MBA
Chief Financial Officer
AC
Adam Crystal, M.D., Ph.D.
Chief Medical Officer
ML
Marc L. Cohen
Co-Founder & Chairman of the Board
View full C4 Therapeutics profile